Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

IJPPE > IJPPE Volume 13 > Preparation of Hybridomas Producing Monoclonal...
< Back to Volume

Preparation of Hybridomas Producing Monoclonal Antibodies against Aflatoxin B1 as a Tool to Control Hepatocellular Carcinoma

Full Text PDF


Hybridomas that secreted antibodies against aflatoxin B1 for multiple uses were prepared using a unique immunization schedule. Aflatoxin B1-BSA conjugate was used for immunization of Balb/c mice. Spleen cells were harvested from the hyper immunized mice to be fused with myeloma cell line (P3NS1) using polyethylene glycol 3000, 50% concentration as a fusogenic agent. The produced hybridomas were selected using HAT selective medium that was replaced by complete HT medium. From the 10th day after fusion, wells that contain colonies of hybridomas covering 30% or greater of the wells surface were screened for production of monoclonal antibodies against aflatoxin B1 using ELISA. 21 hybridomas were found to be reactive to aflatoxin B1. All were found to belong to IgG2a isotype except one was found to belong to IgM isotype. The prepared monoclonal antibodies and their application to immunoassays represents a useful and rapid quantitative measurement with high affinity and low detection limits in order to purify environmentally occurring levels of this carcinogen specially in areas at high risk for liver cancer.


International Journal of Pharmacology, Phytochemistry and Ethnomedicine (Volume 13)
M. M.E. Ahmed et al., "Preparation of Hybridomas Producing Monoclonal Antibodies against Aflatoxin B1 as a Tool to Control Hepatocellular Carcinoma", International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Vol. 13, pp. 1-12, 2019
Online since:
May 2019

[1] D.L. Park, Surveillance programmes for managing risks from naturally occuring toxicants, Food Addit. Contam. 12(3) (1995) 361-371.

[2] D. Bhatnagar, J. Yu, K.C. Erlich, Toxins of filamentous fungi, Chem. Immunol. 81 (2002) 167-206.

[3] V. Vujanovic, W. Smoragiewicz, K. Krzysztyniak, Airborne fungal ecological niche determination as one of the possi-bilities for indirect mycotoxin risk assessment in indoor air, Environ Toxicol. 16(1) (2001) 1–8.


[4] M.A. Diekman, M.L. Green, Mycotoxins and reproduction in domestic livestock, J. Anim. Sci. 70(5) (1992) 1615-1627.

[5] F. Temamogullari, A. Kanici, Short communication: Aflatoxin M1 in dairy products sold in S' anlıurfa, Turkey. J Dairy Sci. 97 (2014) 162e5.


[6] J.S. Wang et al., Development of aflatoxin B (1)-lysine adduct monoclonal antibody for human exposure studies, App. Environ. Microbiol. 67(6) (2001) 2712-2717.

[7] F.S. Chu, Immunochemical studies on mycotoxins, in: H. Kurata, Y. Ueno (Eds.), Toxigenic Fungi, Tokyo, Kodansha ltd, 1984, pp.234-244.

[8] S. Deng, Y. Xu, R. Liu, Mimic epitope of aflatoxin B1 screened by phage display techniquae, Wei. Sheng Yan Jiu. 36(1) (2007) 59-62.

[9] D. Zhang et al., Production of ultrasensitive generic monoclonal antibodies against major aflatoxins using a modified two-step screening procedure, Anal Chim Acta. 639 (2009) 63e9.


[10] J. Wilkinson et al., Immune response to a mucosally administered aflatoxin B1 vaccine. Poult. Sci. 82 (2003) 1565-1572.


[11] Chu, F.S. and Ueno, I. Production of antibody against aflatoxin B1, Appl. Environ. Microbiol. 1977. 33 (5): 1125-1128.

[12] W.C. Davis, T.C. Mcguire, C. Travis, Biomedical and biological application of monoclonal antibody technology in developing countries, Periodicum Biologorum. 85(3) (1983) 259-282.

[13] F.M. Ausubel, R. Brent, Current protocols in molecular biology, John Wiley & Sons, New York, (2003).

[14] Wiggenhauser, A. Jacking blood from mice. Monoclonal antibodies, Peters J.H. and Baumgarten, H. Springer-Verlag Berlin Heidelberg, New York, (1992).

[15] Gast, R.K.; Porter, E.R. and Holt, P.S. Applying tests for specific yolk antibodies to predict contamination by Salmonela enteritidis. Poult. Sci., 1997. 70: 1273-1276.


[16] Ali, M. Monoclonal antibodies production against breast cancer. PH. D thesis, Military Medical Academy, (2001).

[17] Harlow, E. and Lane, D. Antibodies, A laboratory manual. Cold spring laboratory, USA, (1988).

[18] Gefter, M.L.; Margulies, D.L. and Schraff, M.D. A simple method for polyethylene glycol promoted hybridization of mouse myeloma cells. Somatic Cell Genetics, 1977. 3: 231-236.


[19] Amer, H.M. Productio and characterization of monoclonal antibodies to Avian Reo Virus. M.V.Sc., Fac. of Vet. Medicine, Cairo University, (2001).

[20] D.B. Synder et al., Rapid serological profiling by enzyme linked immunosorbent assay. III simultaneous measurements of antibody titer to Infectious bronchitis, Infectious bursal disease and NewCastle disease virus in a serum dilution. Avian Diseases, 1984. 28: 12-24.


[21] Zola, H. Monoclonal antibodies. The basis- Edited by: BIOS Publishers, (2000).

[22] Wogan, G. Mycotoxins. Annu. Rev. Pharmacol., 1975. 15: 437-451.

[23] Anukul N, Vangnai K, Mahakarnchanakul W. Significance of regulation limits in mycotoxins contamination in Asia and risk management programs at the national level. J Food Drug Anal., 2013. 21:227e41.


[24] Bryden, W.L. and Cumming, R.B. Observaton on the liver of the chickens following aflatoxin B1 ingestion. Avian Pathol., 1980. 9: 551-556.

[25] J.S. Virdi et al., Effects of aflatoxin on the immune system of the chick. J. Appl. Toxicol., 1989 9: 271-275.

[26] Glahn, R.P. Mycotoxins and the avian kidney: assessment of physiological function. World's Poult. Sci. J., 1993. 49: 242-250.


[27] R.I. Brown et al., Resistance to aflatoxin accumulation in kernels of maize inbred selected for ear rot resistance in west and central Africa. J. Food Prot., 2001. 64: 396-400.


[28] Moon, E.Y. and Pyo, S. Aflatoxin B1 inhibits CD14-mediated nitric oxide production in murine peritoneal macrophages. Int. J. Immunopharmacol., 2000. 22: 237-246.


[29] H.C. Wu et al., Aflatoxin B1 Exposure, Hepatitis B Virus Infection and Hepatocellular Carcinoma in Taiwan. Cancer Epidemiol.Biomarkers Prev., 2009. 18(3): 846–853.

[30] Reijula, K. and Tuomi, T. Mycotoxins of Aspergilli: Exposure and health effects. Front Biosci., 2003. 1 (8): 232-235.


[31] Ozay, G. and Alperden, I. Aflatoxin and ochratoxin A contamination of dried figs (Ficus Carinal) from the 1988 crop. Mycotox. Res., 1991. 7: 85-97.


[32] Zhang, G. and Chu, F.S. Production and characterization of antibodies cross reactive with major aflatoxins. Experientia, 1989. 45 (2): 182-184.


[33] Kohler and Milstein. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975. 256: 495-497.


[34] Hay Frank, C. and Westwood Olwyn, M.R. Practical immunology-Monoclonal antibodies: Production, purification and enzymatic fragmentation. PP.: 40-70. 4th edition, Black well science, (2002).


[35] Candlish, A.A.; Stimson, W.H. and Smith, J.E. A monoclonal antibody to aflatoxin B1: Detection of the mycotoxin by enzyme immunoassay. Lett. Appl. Microbiol., 1985. 1: 57-61.


[36] Ward, C.M.; Wilkinson, A.P.; Bramham, S.; Lee, H.A.; Chan, H.W.; Butcher, G.W.; Hutchings, H. and Morghan, M.R.A. Production and characterization of polyclonal and monoclonal antibodies against aflatoxin B1 oxime-BSA in an enzyme linked immunosorbent assay. Mycotox. Res., 1990. 6: 73-83.


[37] Devi, K.T.; Mayo, M.A.; Reddy, K.L.; Delfosse, P.; Reddy, G.; Reddy, S.V. and Reddy, D.V. Production and characterization of monoclonal antibodies for aflatoxin B1. Lett. Appl. Microbiol., 1999. 29: 284-288.


[38] Kane, M. and Banks, J.N. Raising antibodies.Cited from immunoassays. A practical approach. Edited by J. Gosling, Department of biochemistry and national diagnostic center, National Univeristy of Ireland galls way (Oxford Univeristy), 2000. PP.: 19-58.

[39] Farzad, Z. and James, K. Measurement of human and mouse anti-tetanus antibodies and isotype analysis by ELISA. J. of Immunol. Methods, 1986. 87 (1): 119-125.


[40] Quinlan and Kennedy. Enhanced cloning efficiencies of murine hybridomas using human plasma supplemented medium. J. Immunol. Methods, 1994. 123: 157-165.


[41] Davidsen, R. and Land Gerald, P.S. Improved techniques for the induction of mammalian cell hybridization by PEG. Somatic Cell Genetics, 1976. 2 (2): 165-176.

[42] Zola, H. and Holbrook, F.L. Tolerization as a tool for generation novel monoclonal antibodies. Immunol. Cell Biol., 2002. 80 (4): 319-322.


[43] Schidegger, D. and DE Groth, S.F. Production of monoclonal antibodies: Strategy and tactics. J. Immunol. Methods, 1980. 35 (1-2): 1-21.

[44] Kenimer James, G. and William, H. Monoclonal antibodies as probes of Tetanus toxin structure and function. Infection and Immunity, 1983. 42 (3): 942-948.

[45] J. Sheppard Anthony, D. Cusell, Production and characterization of monoclonal antibodies to tetanus toxin, Infect. Immunity. 43(2) (1983) 710-714.

[46] M. Little, F.L. Gall, Of mice and men: Hybridoma and recombinant antibodies, Immunol. Today. 21(8) (2000) 355-412.

[47] W.A. Volk, B. Bizzini, Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule, Infection and Immunity, 1984, pp.604-609.

Show More Hide
Cited By:
This article has no citations.